ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Technology Services

M3, Inc.

Business Summary

M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, Overseas, and Other Emerging Businesses. The Medical Platform segment handles domestic marketing-related services that uses the Internet. It also operates the medical professional site, m3.com. The Evidence Solution segment offers business support for clinical trials. It also manages overall clinical trial operations. The Career Solution segment deals with human resources service business for medical professionals in Japan. The Site Solutions segment covers medical institution management support and home-visit nursing businesses. The Overseas segment provides services such as marketing support, research, clinical trial support, and human resources services for medical companies that use medical professional sites in the United States, United Kingdom, China, South Korea, India, France, Germany, and Spain. The Other Emerging Businesses segment includes consumer services, and medical and welfare national examination preparation services. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2021 JPYUSD
Revenue169,198M1,595.34M
Gross Profit99,268M935.98M
Operating income58,362M550.28M
Income before tax58,292M549.62M
Net income37,822M356.61M
EBITDA64,099M604.38M
Diluted EPS55.670.52
Dividends Per Share120.11
Total Assets273,123M2,471.70M
Total liabilities65,863M596.04M
Total equity199,813M1,808.26M
Operating cash flow46,627M439.63M
Currency in JPYCurrency in USD

Historical Data

 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 78,143M 94,471M 113,059M 130,973M 169,198M
Gross Profit 45,444M 53,016M 62,884M 69,759M 99,268M
Operating income 23,985M 26,907M 27,837M 34,294M 58,362M
Income before tax 24,959M 27,472M 30,942M 34,610M 58,292M
Net income 16,004M 18,127M 19,577M 21,635M 37,822M
EBITDA 24,924M 28,068M 29,228M 38,788M 64,099M
Diluted EPS 24.70 27.97 30.20 31.87 55.67
Dividends Per Share 5 5.50 7 8.50 12
Total Assets 95,546M 116,441M 137,306M 221,839M 273,123M
Total liabilities 26,021M 31,272M 35,029M 50,238M 65,863M
Total equity 67,064M 82,483M 98,733M 166,111M 199,813M
Operating cash flow 16,555M 15,913M 17,749M 26,789M 46,627M
 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 721.62M 852.37M 1,019.51M 1,204.61M 1,595.34M
Gross Profit 419.66M 478.34M 567.06M 641.60M 935.98M
Operating income 221.49M 242.77M 251.02M 315.41M 550.28M
Income before tax 230.48M 247.86M 279.02M 318.32M 549.62M
Net income 147.79M 163.55M 176.53M 198.98M 356.61M
EBITDA 230.16M 253.24M 263.56M 356.75M 604.38M
Diluted EPS 0.22 0.25 0.27 0.29 0.52
Dividends Per Share 0.04 0.04 0.06 0.07 0.11
Total Assets 857.45M 1,094.88M 1,240.51M 2,054.92M 2,471.70M
Total liabilities 233.51M 294.04M 316.47M 465.36M 596.04M
Total equity 601.84M 775.58M 892.01M 1,538.70M 1,808.26M
Operating cash flow 152.88M 143.57M 160.05M 246.39M 439.63M

Valuation Measures

Mar 2021
PER135.85
ROA15.28%
ROE20.67%
Operating margin34.49%
Profit margin22.35%

Key executives

  • President & Representative Director: Itaru Tanimura
  • Director: Eiji Tsuchiya

Shareholders

  • Sony Group Corp. (33.9%)
  • Baillie Gifford & Co. (8.2%)
  • Nomura Asset Management Co., Ltd. (5.9%)
  • Capital Research & Management Co. (World Investors) (2.9%)
  • Nippon Telegraph & Telephone Corp. (2.9%)
  • Nikko Asset Management Co., Ltd. (2.8%)
  • TANIMURA ITARU (2.8%)
  • Daiwa Asset Management Co. Ltd. (2.5%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (2.1%)
  • The Vanguard Group, Inc. (1.6%)

Contact Details

  • Website:http://corporate.m3.com
  • Address: Akasaka Intercity, 10/F, 1-11-44 Akasaka, Tokyo, 107-0052, Japan
  • Phone: +81.3.6229.8900

Related Companies

  • M3, Inc. (Fund OPD)
  • Towa Sangyo Co., Ltd. (Osaka)
  • ONEhealth Communications Ltd.
  • Vidal France SA
  • M3 (EU) Ltd.
  • M3 Medical Holdings Ltd.
  • Medical Agency KK
  • Edanz Group Japan, Inc.
  • Neuroglia Health Pvt Ltd.
  • Shin Nippon Biomedical Laboratories SMO Ltd.
  • iG-Holdings, Inc. (Japan)
  • M3 Doctor Support, Inc.
  • M3i, Inc.
  • Clinical Porter, Inc.
  • Nouvelle Place, Inc.
  • M3 Marketing, Inc.
  • DailyRounds, Inc.
  • e- SMO KK
  • M Cube, Inc.
  • Fuji CRS KK
  • QLife, Inc.
  • M3 USA Corp.
  • Medi C&C Co., Ltd.
  • C.M.S Co. Ltd.
  • Nihon Ultmarc, Inc.
  • Cosmotec Co., Ltd.
  • SmartestDoc LLC
  • Neues Co. Ltd.
  • Manthan Software Services Pvt Ltd.
  • MIC Medical Corp.

Competitors

    Last Updated on 1 Dec, 2021

    Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

    Celebrate our next chapter
    Free access for everyone - Sep. 30

    Find out more